Found: 82
Select item for more details and to access through your institution.
Design of the Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) trial.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1275, n. 1, p. 17, doi. 10.1111/j.1749-6632.2012.06780.x
- By:
- Publication type:
- Article
AI driven analysis of MRI to measure health and disease progression in FSHD.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65802-x
- By:
- Publication type:
- Article
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.
- Published in:
- Annals of Neurology, 2008, v. 63, n. 5, p. 561, doi. 10.1002/ana.21338
- By:
- Publication type:
- Article
Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis.
- Published in:
- Annals of Neurology, 2005, v. 57, n. 5, p. 664
- By:
- Publication type:
- Article
Randomized trials of dichlorphenamide in the periodic paralyses.
- Published in:
- Annals of Neurology, 2000, v. 47, n. 1, p. 46, doi. 10.1002/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H
- By:
- Publication type:
- Article
Facioscapulohumeral dystrophy: A distinct regional myopathy with a novel molecular pathogenesis.
- Published in:
- Annals of Neurology, 1998, v. 43, n. 3, p. 279, doi. 10.1002/ana.410430303
- By:
- Publication type:
- Article
Evidence for anticipation and association of deletion size with severity in facioscapulohumerd muscular dystrophy.
- Published in:
- Annals of Neurology, 1996, v. 39, n. 6, p. 744, doi. 10.1002/ana.410390610
- By:
- Publication type:
- Article
Reply.
- Published in:
- Annals of Neurology, 1994, v. 36, n. 2, p. 253, doi. 10.1002/ana.410360224
- By:
- Publication type:
- Article
Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features.
- Published in:
- Annals of Neurology, 1994, v. 35, n. 3, p. 326, doi. 10.1002/ana.410350313
- By:
- Publication type:
- Article
A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.04996.001
- By:
- Publication type:
- Article
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Relationship of DUX4 and target gene expression in FSHD myocytes.
- Published in:
- Human Mutation, 2021, v. 42, n. 4, p. 421, doi. 10.1002/humu.24171
- By:
- Publication type:
- Article
Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei.
- Published in:
- European Journal of Human Genetics, 2010, v. 18, n. 4, p. 448, doi. 10.1038/ejhg.2009.183
- By:
- Publication type:
- Article
Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.
- Published in:
- European Journal of Human Genetics, 2009, v. 17, n. 12, p. 1615, doi. 10.1038/ejhg.2009.62
- By:
- Publication type:
- Article
Splicing biomarkers of disease severity in myotonic dystrophy.
- Published in:
- Annals of Neurology, 2013, v. 74, n. 6, p. 862, doi. 10.1002/ana.23992
- By:
- Publication type:
- Article
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
DUX4 Binding to Retroelements Creates Promoters That Are Active in FSHD Muscle and Testis.
- Published in:
- PLoS Genetics, 2013, v. 9, n. 11, p. 1, doi. 10.1371/journal.pgen.1003947
- By:
- Publication type:
- Article
Intrinsic Epigenetic Regulation of the D4Z4 Macrosatellite Repeat in a Transgenic Mouse Model for FSHD.
- Published in:
- PLoS Genetics, 2013, v. 9, n. 4, p. 1, doi. 10.1371/journal.pgen.1003415
- By:
- Publication type:
- Article
K-40 and Dual-Energy X-ray Absorptiometry Estimates of Lean Weight Compared: Normals and Patients with Neuromuscular Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 904, n. 1, p. 111, doi. 10.1111/j.1749-6632.2000.tb06431.x
- By:
- Publication type:
- Article
The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS).
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 7, p. 2339, doi. 10.1111/ene.14863
- By:
- Publication type:
- Article
A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics.
- Published in:
- Journal of Neuromuscular Diseases, 2023, v. 10, n. 6, p. 1031, doi. 10.3233/JND-221636
- By:
- Publication type:
- Article
Understanding the Perseverance of the Muscular Dystrophy Community One-Year into the COVID-19 Pandemic.
- Published in:
- Journal of Neuromuscular Diseases, 2022, v. 9, n. 4, p. 517, doi. 10.3233/JND-220794
- By:
- Publication type:
- Article
Current Therapeutic Approaches in FSHD.
- Published in:
- Journal of Neuromuscular Diseases, 2021, v. 8, n. 3, p. 441, doi. 10.3233/JND-200554
- By:
- Publication type:
- Article
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 20, p. 4419, doi. 10.1093/hmg/ddw271
- By:
- Publication type:
- Article
DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHD.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 17, p. 4817, doi. 10.1093/hmg/ddv206
- By:
- Publication type:
- Article
Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 3, p. 659, doi. 10.1093/hmg/ddu486
- By:
- Publication type:
- Article
DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 20, p. 5342, doi. 10.1093/hmg/ddu251
- By:
- Publication type:
- Article
Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 23, p. 4661, doi. 10.1093/hmg/ddt314
- By:
- Publication type:
- Article
RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy.
- Published in:
- Human Molecular Genetics, 2009, v. 18, n. 13, p. 2414, doi. 10.1093/hmg/ddp180
- By:
- Publication type:
- Article
Asymmetric Bidirectional Transcription from the FSHD-Causing D4Z4 Array Modulates DUX4 Production.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035532
- By:
- Publication type:
- Article
Sex-Related Differences in Gene Expression in Human Skeletal Muscle.
- Published in:
- PLoS ONE, 2008, v. 3, n. 1, p. 1, doi. 10.1371/journal.pone.0001385
- By:
- Publication type:
- Article
Facioscapulohumeral Dystrophy.
- Published in:
- Current Neurology & Neuroscience Reports, 2016, v. 16, n. 7, p. 1, doi. 10.1007/s11910-016-0667-0
- By:
- Publication type:
- Article
Facioscapulohumeral muscular dystrophy.
- Published in:
- Current Neurology & Neuroscience Reports, 2004, v. 4, n. 1, p. 51, doi. 10.1007/s11910-004-0012-x
- By:
- Publication type:
- Article
A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
- Published in:
- Muscle & Nerve, 2024, v. 69, n. 3, p. 362, doi. 10.1002/mus.28031
- By:
- Publication type:
- Article
Milestones of progression in myotonic dystrophy type 1 and type 2.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole‐body fat‐referenced MRI: Protocol development, multicenter feasibility, and repeatability.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 2, p. 183, doi. 10.1002/mus.27638
- By:
- Publication type:
- Article
Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 1, p. 50, doi. 10.1002/mus.27558
- By:
- Publication type:
- Article
A patient‐focused survey to assess the effects of the COVID‐19 pandemic and social guidelines on people with muscular dystrophy.
- Published in:
- Muscle & Nerve, 2021, v. 64, n. 3, p. 321, doi. 10.1002/mus.27349
- By:
- Publication type:
- Article
Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long Exercise Test in Periodic Paralysis: A Bayesian Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Facioscapulohumeral muscular dystrophy functional composite outcome measure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Review of the Diagnosis and Treatment of Periodic Paralysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Episodic weakness and Charcot-marie-tooth disease due to a mitochondrial MT-ATP6 mutation.
- Published in:
- 2017
- By:
- Publication type:
- case study
Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Electrical impedance myography in facioscapulohumeral muscular dystrophy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells.
- Published in:
- Skeletal Muscle, 2017, v. 7, p. 1, doi. 10.1186/s13395-017-0134-x
- By:
- Publication type:
- Article